Vergis, Marissa .

HRN: 29-06-86  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2026
AMPICILLIN 1GM (VIAL)
05/28/2026
05/30/2026
IV
2g
Every 6h
PROM
Checking Initial Appropriateness 
05/28/2026
AZITHROMYCIN 500MG TABLET (TAB)
05/28/2026
05/28/2026
PO
500mg
Single Dose Only
PROM
Checking Initial Appropriateness 
05/29/2026
CEFUROXIME 500MG (TAB)
05/29/2026
06/05/2026
PO
500mg
BID
Thickly MSAF
Checking Initial Appropriateness 
05/29/2026
METRONIDAZOLE 500MG (TAB)
05/29/2026
06/05/2026
PO
500mg
TID
Thickly MSAF
Checking Initial Appropriateness 
05/29/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/29/2026
05/30/2026
IV
300 Mg
Every 8 Hrs For 3 Doses
PROM
Checking Initial Appropriateness 
05/29/2026
CLINDAMYCIN 300MG (CAP)
05/29/2026
06/05/2026
PO
300mg
TID
PROM
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: